Future Market Insights forecasts the global diabetic macular edema
market to grow from nearly US$ 3,710 Mn in 2017 to over US$ 4,100 Mn
by 2027 end. This represents a CAGR of 1.1% over the forecast period
of 2017– 2027. North America is projected to be the largest market
in terms of value and accounted for the highest revenue share of
51.5% in 2016.
By product form, intravitreal injections will continue to be
sought-after in the market, with sales poised to surpass US$ 4,000 Mn
by 2027-end. Sales of intravitreal implants will register a
comparatively higher CAGR than intravitreal injections through 2027.
North America will remain dominant in the global diabetic macular
edema market. An uptake of intravitreal implants by new as well as
existing patients, who do not show any improvement post-treatment
with intravitreal injections, is expected to sustain growth of the
market in this region.
The diabetic macular edema market in Western Europe is expected to
register a comparatively higher CAGR than other region segments
through 2027. Pharmaceutical companies in this region are making
substantial investments in research and development, new
technologies, and infrastructure in order to capture a market share
in the surging burden of eye diseases. This is expected to retain
growth of the market in Western Europe.
However, patients in Western Europe resist the intake of intravitreal
injections of anti-VEGF drugs, which leads to an instant increase in
intraocular pressure causing severe pain in the head or eyes. This a
major factor impeding growth of the diabetic macular edema market in
Western Europe.
Request to sample report@
https://www.futuremarketinsights.com/reports/sample/rep-gb-2697
Summary of Table of Content
1. Executive Summary
2. Market Introduction
3. Diabetic Macular Edema Market View Point
4. North America Diabetic Macular Edema Market Analysis 2012–2016
and Forecast 2017–2027
5. Western Europe Diabetic Macular Edema Market Analysis 2012–2016
and Forecast 2017–2027
6. Eastern Europe Diabetic Macular Edema Market Analysis 2012–2016
and Forecast 2017–2027
7. Latin America Diabetic Macular Edema Market Analysis 2012–2016
and Forecast 2017–2027
8. Asia Pacific Excluding Japan Diabetic Macular Edema Market
Analysis 2012–2016 and Forecast 2017–2027
9. Japan Diabetic Macular Edema Market Analysis 2012–2016 and
Forecast 2017–2027
10. Middle East and Africa Diabetic Macular Edema Market Analysis
2012–2016 and Forecast 2017–2027
11. Forecast Factors: Relevance and Impact
12. Forecast Assumptions
13. Competition Landscape
14. Global Diabetic Macular Edema Market Analysis 2012–2016 and
Forecast 2017–2027 By Region
15. Global Diabetic Macular Edema Market Analysis 2012–2016 and
Forecast 2017–2027, By Product Type
16. Global Diabetic Macular Edema Market Analysis 2012–2016 and
Forecast 2017–2027, By Product Form
17. Global Diabetic Macular Edema Market Analysis 2012–2016 and
Forecast 2017–2027, By Distribution Channel
18. Global Diabetic Macular Edema Market Analysis 2012–2016 and
Forecast 2017–2027
19. Assumptions and Acronyms Used
20. Research Methodology
Request to Browse Full Table of Content, figure and Tables@
https://www.futuremarketinsights.com/toc/rep-gb-2697
ABOUT US:
Future Market Insights (FMI) is a leading market intelligence and
consulting firm. We deliver syndicated research reports, custom
research reports and consulting services, which are personalized in
nature. FMI delivers a complete packaged solution, which combines
current market intelligence, statistical anecdotes, technology
inputs, valuable growth insights, an aerial view of the competitive
framework, and future market trends.
CONTACT:
Future Market Insights
616 Corporate Way, Suite 2-9018,
Valley Cottage, NY 10989,
United States
T: +1-347-918-3531
F: +1-845-579-5705
Email: sales@futuremarketinsights.com
Website: www.futuremarketinsights.com
No comments:
Post a Comment